Press release
Empowering Neuroprotection: Market Growth Projections & Trends 2024-2031
Neuroprotection Market - DataM Intelligence
Neuroprotection Market is expected to grow at a CAGR of 8.2% during the forecast period 2024-2031
Neuroprotection refers to the capacity to promote recovery, salvage, and regeneration of the nervous system's structure, cells, and functions. It involves the prevention of neuronal cell death by inhibiting pathogenic cascades that lead to cellular dysfunction.
Various neurochemical modulators can cause damage to the nervous system, highlighting the importance of therapeutic approaches aimed at preserving neuronal integrity and function. The ultimate goal of neuroprotection is to mitigate the harmful effects of neurodegenerative processes and enhance the brain's resilience to injury or disease.
For More Insights Request Free Sample: https://www.datamintelligence.com/download-sample/neuroprotection-market
Neuroprotection Market Trends
The neuroprotection market is expected to experience significant growth driven by increasing investment in research and development (R&D), rising novel product launches, and ongoing drug discovery efforts. The growing adoption of neuroprotection products for the prevention and treatment of various neurodegenerative disorders, including Parkinson's disease and multiple sclerosis, is fueling market expansion. Additionally, the escalating prevalence of neurological diseases further contributes to market growth, prompting increased R&D activities by healthcare companies aimed at developing innovative products.
Neuroprotection finds application in a wide range of disorders such as stroke, trauma, Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, and spinal muscular atrophy. The market for these applications is expanding globally in response to the rising incidence of these conditions. Moreover, the availability of technologically advanced products from key players is expected to drive market growth.
The market's growth is also supported by various factors such as novel product launches, regulatory approvals, and ongoing research studies. For example, on July 5, 2022, Biogen Inc. and Eisai Co., Ltd. announced that their Biologics License Application (BLA) for lecanemab, an investigational antibody targeting anti-amyloid beta (Aβ) protofibrils, was accepted by the U.S. Food and Drug Administration. Lecanemab is intended for the treatment of mild cognitive impairment caused by Alzheimer's disease and mild Alzheimer's disease with amyloid pathology in the brain, representing a significant advancement in neuroprotection therapy.
View Full Report: https://www.datamintelligence.com/research-report/neuroprotection-market
Neuroprotection Industry Segmentation
By Product Type
Anti-Inflammatory Agents
Free Radical Trapping Agents
Anti-Excitotoxic Agents
Apoptosis Inhibitors
Iron Chelators
Neurotrophic Factors
Stimulants
Gene Therapy
By Type
Prevention
Treatment
By Application
Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Stroke
Spinal Muscular Atrophy
Huntington's Disease
Creutzfeldt-Jakob disease (CJD)
Others
By End-User
Hospitals
Specialty Clinics
Market Key Players
Major players are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novartis AG, AstraZeneca, Teva Pharmaceutical Industries Ltd., Biogen, Astrocyte Pharmaceuticals, Inc., AbbVie Inc., Medtronic and Merck KGaA.
Trending Reports
Pediatric Neurology Devices Market - https://www.datamintelligence.com/research-report/pediatric-neurology-devices-market
Neurovascular Embolization Devices Market - https://www.datamintelligence.com/research-report/neurovascular-embolization-devices-market
Neurorehabilitation Devices Market - https://www.datamintelligence.com/research-report/neurorehabilitation-devices-market
EEG Electrodes Market - https://www.datamintelligence.com/research-report/eeg-electrodes-market
Contact Us:
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Empowering Neuroprotection: Market Growth Projections & Trends 2024-2031 here
News-ID: 3393201 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Point-of-Care Ultrasound Market is expected to reach US$ 4.60 bill …
Market Size and Growth:
The Global Point-of-Care Ultrasound Market size reached US$ 1.99 billion in 2023, with a rise to US$ 2.16 billion in 2024, and is expected to reach US$ 4.60 billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033. The Market is growing due to the increasing demand for rapid, bedside diagnostics and advancements in portable ultrasound technology.
Get a Free Sample PDF Of This…
United States Vagus Nerve Stimulators Market Set for Explosive Growth: Innovatio …
Market Overview:
The Global Vagus Nerve Stimulators Market is expected to grow at a CAGR Of 8.9% during the forecast period 2024-2031. The Market is growing due to the rising prevalence of neurological disorders and increasing adoption of advanced neuromodulation therapies for conditions like epilepsy and depression.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/vagus-nerve-stimulators-market?sz
The Vagus Nerve Stimulators (VNS) Market encompasses the global industry…
United States Keloid Treatment Market Set to Surge: Innovative Therapies Driving …
Market Overview:
The Keloid Treatment Market is expected to reach at a CAGR of 9.9% during the forecast period (2024-2031). The Market is growing due to the rising prevalence of keloid scars, increasing awareness of advanced treatment options, and growing demand for cosmetic and dermatological procedures.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/keloid-treatment-market?sz
The Keloid Treatment Market encompasses therapies, medications, and medical devices designed…
United States Ambulatory Surgical Centers Market is estimated to reach US$ 149,7 …
Market Size and Growth:
The Ambulatory Surgical Centers Market size was valued at US$ 82,938.67 million in 2022 and is estimated to reach US$ 149,758.34 million by 2031, growing at a CAGR of 8.26% during the forecast period (2024-2031). The Market is growing due to the rising demand for cost-effective, convenient, and minimally invasive surgical procedures.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/ambulatory-surgical-centers-market?sz
The…
More Releases for Neuroprotection
Breakthrough in Neuroprotection: Nooglutil Shows Promise in Preclinical Studies
A novel neuroprotective agent, Nooglutil [https://www.biofingredients.com/biof-supply-nooglutil-cas-112193-35-8-n-5-hydroxy-3-pyridinylcarbonyl-l-glutamic-acid-product/], has emerged as a promising candidate for treating neurodegenerative disorders, according to recent preclinical research. Developed to address unmet medical needs in Alzheimer's disease (AD), Parkinson's disease (PD), and stroke recovery, Nooglutil combines two active components-nopracitabine and gyltio clone-to enhance neuronal resilience and cognitive function through dual mechanisms.
Mechanism and Preclinical Efficacy
Nopracitabine, a natural neurotransmitter precursor, promotes acetylcholine synthesis, critical for memory and learning .…
Neuroprotection: A Guide to Understanding the Process
Neuroprotection is involvement capable to affect the etiology or the pathogenesis of the neurodegenerative diseases. They delay the onset or the development of neurodegenerative diseases. Neuroprotective products are medications that protect the brain neurons from deterioration and injury.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPMD00002291/?utm_source=OpenPR&utm_medium=10129
These products are used in the cure of several central nervous system complications such as Alzheimer's disease, Parkinson's disease and traumatic brain injuries…
Neuroprotective Agents Market - Empowering Neuroprotection for Optimal Brain Fun …
Newark, New Castle, USA: The "Neuroprotective Agents Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Neuroprotective Agents Market: https://www.growthplusreports.com/report/neuroprotective-agents-market/8412
This latest report researches the industry structure, sales, revenue,…
Neuroprotection Market Share, Sales Channels and Overview Till 2028
Neuroprotection is involvement capable to affect the etiology or the pathogenesis of the neurodegenerative diseases. They delay the onset or the development of neurodegenerative diseases. Neuroprotective products are medications that protect the brain neurons from deterioration and injury. These products are used in the cure of several central nervous system complications such as Alzheimer's disease, Parkinson's disease and traumatic brain injuries among others. Neuroprotective agents in clinical pipelines comprise small-molecule…
Global Neuroprotection Market Research
The Global Neuroprotection Market Research Global Neuroprotection Market Research neuroprotection showcase was esteemed at roughly US$ 47,000.0 Mn in 2016 is anticipated to enroll a development rate of 8.2% from 2017 to 2025, as per another report distributed by Transparency Market Research (TMR) titled "Neuroprotection Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017– 2025". The Global Neuroprotection Market Research report proposes that expanding occurrence and predominance…
Neuroprotection Market to Expand with Significant CAGR by 2025
The global Neuroprotection Market was valued at approximately US$ 47,000.0 Mn in 2016 is projected to register a growth rate of 8.2% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Neuroprotection Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that increasing incidence and prevalence rates of neurological disorders such as Alzheimer’s, Parkinson’s, Macular Sclerosis ,and…
